Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.

Theranostics · 2021 · PMC8058708 · PMID 33897892

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

extremely significantno p-value reported

* P < 0.05 was considered statistically significant, ** P < 0.01 was considered highly significant, *** P < 0.001 and **** P < 0.0001 were considered extremely significant, and ns was considered not significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.